Technische Universität München
München, Bavaria, 80636, Germany
NCT Number: NCT01230086
Implantation of a cardioverter defibrillator (ICD) is the treatment of choice for primary and secondary prevention of sudden cardiac death. Traditionally, intraoperative testing for sensing and defibrillation capabilities of the ICD system is performed. Modern implantation strategies suggest a non-testing approach because net-benefit of a testing versus a non-testing strategy is questionable and because arrhythmia induction and defibrillation may cause micro damage to the heart.
The study aims to investigate the contribution of different steps in the ICD implantation procedure (implantation of the lead, shock delivery and induced ventricular fibrillation) with respect to their potential damage to the heart measured by high sensitivity (HS) TroponinT.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 4
München, Bavaria, 80636, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantation
Upper limit of vulnerability testing
Traditional safety margin testing for defibrillation threshold
Time frame: 6 hours
Time frame: 6 hours
Deutsches Herzzentrum Muenchen
Other
hs Troponin Release in Relation to Different ICD-Implantation Procedures
Acronym: Trop-Shock
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.